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Characteristics No Hand OA
(n ¼ 140)








Waist Circumference > 40inches
in men, >35 inches in women
122 87.1% 68 94.4% 0.099
Knee KL grade >¼2 139 99.3% 69 95.8% 0.372
Cigarette Smoking Current 59 42.1% 34 47.2% 0.676
Metabolic Syndrome
2 or more metabolic factors
90 64.3% 55 76.4% 0.073
Metabolic Syndrome
3 or more metabolic factors
29 20.7% 24 33.3% 0.044
Metabolic Syndrome Score 0–1 2 3–4 506129 35.7%43.6%20.7% 173124 23.6%43.1%33.3% 0.073 0.023
BMI (Mean, SD) 29.7 (4.8) 29.2 (3.8) 0.424
Age (mean, SD) 59.75 (8.01) 68.11 (6.63) <0.001
Physical Activity PASE (Mean, SD) 168.63 (86.78) 131.54 (72.54) 0.002
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Purpose: To produce UK population-based estimates of elapsed time
from ﬁrst diagnosis of hip/knee osteoarthritis (OA) to primary sur-
gery for those undergoing total joint replacement (TJR) of the hip
(THR) or knee (TKR). These gender-speciﬁc estimates will compare
results for hip and knee using annual summary statistics over a 20
year period.
Methods: We used data from the General Practice Research Database
(GPRD) containing all the computerised records of 6.25m patients, and
representative of the population of the UK. We collected data on all
THRs (N ¼ 20,739) and TKRs (N ¼ 21,715) performed between 1991 and
2010 which also have a reliable prior diagnosis of site-speciﬁc OA. The
distribution of diagnosis-to-TJR time was skewed so we used a log
transformation before comparisons using t tests. As a sensitivity we
used Mann-Whitney tests on untransformed time-to-TJR. Plots com-
paring median diagnosis-to-TJR time for hip and knee, male and female
and younger and older subjects were produced for the 20-year study
period.
Results: Median diagnosis-to-TJR time was 15.5 months (interquartile
range[IQR] 6.7–41.3) for hip, and 38.3 (IQR: 13.7–96.1) for knee over the
entire study period. Overall, and for each individual calendar year
between 1991 and 2006, the timewas signiﬁcantly less for hips than for
knees (p < 0.0001 for all years) when using log time in t tests. Gender-
speciﬁc tests gave similar results (women: p< 0.0001 for all years, men:
p<0.0001 for 1995 onwards). The same tests, but using Mann-Whitney
on untransformed time-to-TJR, also produced a consistent strength and
direction of association with women p < 0.0001 for all years except
1991 (p ¼ 0.0018) and 1993 (p ¼ 0.0002), and men (p < 0.0001 for 1995
onwards). Median time-to-TJR for men was similar to that for women,
both for hips (women 15.0 months; men 16.3) and knees (women 36.9;
men 40.3). However, we did ﬁnd that for both hips and knees, subjects
aged less than 65 at OA diagnosis had a signiﬁcantly greater time-to-TJR
than those aged 65 or over, but we did not ﬁnd any differences in time-
to-TJR when comparing obese (body mass index >¼ 30) to non-obese
subjects.
Conclusions: Using population-based data, we have described
the temporal proﬁle of the time between diagnosis of hip/knee OA
and subsequent TJR. Limitations include the fact that no data on
disease severity at diagnosis was available. Also we did not
account for other interventions which might delay eventual TJR,
but it is suggested that these factors are unlikely to have a dra-
matic effect on the differences in time-to-TJR between hip and
knee.374
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Purpose: Joint replacement surgery is a common treatment for severe
osteoarthritis (OA). The rising prevalence of OA has contributed to
increased volumes of joint replacements being performed worldwide.
With a variety of joint replacement techniques and prostheses available
on the market, evaluating the safety, effectiveness, and quality of joint
replacements has become critical from both clinical and healthcare
system perspectives. Joint replacement registries (JRRs) have become
an important source for monitoring, comparing, and improving joint
replacement outcomes. A main focus of recently developed interna-
tional registry organizations, including the International Society of
Arthroplasty Registers (ISAR) and International Consortium of Ortho-
paedic Registries, has been to encourage collaborations between JRRs to
improve evaluation and better understand variability in joint replace-
ment outcomes. However, differences in deﬁnitions and methods of
analysis and reporting of important outcomes, such as revisions rates
and patient-reported outcome measures (PROMs), limit the ability to
make meaningful comparisons across JRRs. Our objective was to assess
the comparability of JRR data by examining the deﬁnitions, analyses,
and outcomes reported by established hip JRRs.
Methods: To ensure high-quality hip JRRs were included, we identiﬁed
full (national JRRs with over 80% national validated data) or associate
(national JRRs with under 80% national data or no validation processes,
